Focus on HIV Care

Back to articles

Two-drug regimens might be as effective as three-drug regimens for HIV-1 infections


The fixed-dose combination regimen of dolutegravir/rilpivirine (Juluca—ViiV Healthcare) administered as one tablet daily was found to be noninferior to traditional three-drug antiviral regimens for management of HIV-1 infections, according to pooled results from the SWORD-1 and -2 trials published in Lancet.